Energy's up, strength's climbing, body composition's shifting
Written by Glunova Medical Team Clinical Research & Health Content Editorially reviewed by Glunova Medical Review Board Medical Advisory Panel This guide is for educational purposes only and is not a substitute for medical advice, diagnosis, or treatment
If symptoms persist beyond two weeks or worsen, contact your GP for review
But I know what youre thinking Why not just inject HGH itself
Interest in GIPR agonism for the treatment of obesity and diabetes was recently propelled by the clinical success of unimolecular dual-agonists targeting the receptors for GIP and GLP-1, with reported significantly improved body weight and glucose control in patients with obesity and type II diabetes
In fact, a study published (5) in the Journal of Aging and Physical Activity found that stopping supplementation while continuing to train at a reduced volume did not lead to muscle loss or strength declines